Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Sanofi takeover bid rebuffed by Medivation

Sanofi takeover bid rebuffed by Medivation Meanwhile, Medivation has a well-regarded cancer pipeline headed by PARP inhibitor talazoparib (MDV3800) - licensed from BioMarin - in phase III trials for the treatment of patients with breast cancer whose BRCA

FDA rejects PTC's application for muscular dystrophy drug

FDA rejects PTC's application for muscular dystrophy drug Translarna is intended to treat DMD caused by nonsense mutations in the dystrophin gene and works via a slightly different mechanism to other DMD therapies coming through the pipeline, including

Deal Watch October 2015

Deal Watch October 2015 This month's deal between Merck Serono (Merck KGaA) and BioMarin is a good example of this approach. ... Acquisition - company. 580. Merck Serono/ BioMarin. Kuvan and pegvaliase (Kuvan marketed; pegvaliase p3).

FDA panel rejects BioMarin's muscular dystrophy drug

FDA panel rejects BioMarin's muscular dystrophy drug Fails to convince committee of its safety and efficacy. BioMarin has failed to convince an FDA advisory committee that its Kyndrisa therapy for Duchenne muscular dystrophy (DMD) is either safe or ... BioMarin acquired rights to drisapersen via its $840m

BioMarin's real world data sways NICE on orphan drug Vimizim

BioMarin's real world data sways NICE on orphan drug Vimizim Rare genetic disorder treatment recommended in final draft guidance. NICE has issued final draft guidance recommending BioMarin Pharma's Vimizim (elosulfase alfa) for the treatment of the rare genetic disorder Morquio

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics